
David W. Berke-schlessel
Examiner (ID: 6754, Phone: (571)270-3643 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1651, 1799 |
| Total Applications | 867 |
| Issued Applications | 517 |
| Pending Applications | 104 |
| Abandoned Applications | 260 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14439621
[patent_doc_number] => 20190177683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => STABILIZATION OF ENZYME-IMMOBILIZED HYDROGELS FOR EXTENDED HYPOXIC CELL CULTURE
[patent_app_type] => utility
[patent_app_number] => 16/212212
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16212212
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/212212 | Stabilization of enzyme-immobilized hydrogels for extended hypoxic cell culture | Dec 5, 2018 | Issued |
Array
(
[id] => 14227257
[patent_doc_number] => 20190125801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/212578
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16212578
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/212578 | Tumoricidal and antimicrobial compositions and methods | Dec 5, 2018 | Issued |
Array
(
[id] => 14808805
[patent_doc_number] => 20190271012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => METHOD FOR PRODUCING A LONG CHAIN DICARBOXYLIC ACID BY FERMENTATION, FERMENTATION BROTH, TREATED FERMENTATION BROTH AND WASTEWATER
[patent_app_type] => utility
[patent_app_number] => 16/207721
[patent_app_country] => US
[patent_app_date] => 2018-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16207721
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/207721 | Method for producing a long chain dicarboxylic acid by fermentation, fermentation broth, treated fermentation broth and wastewater | Dec 2, 2018 | Issued |
Array
(
[id] => 18801526
[patent_doc_number] => 11834678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Hematopoietic stem cells with improved properties
[patent_app_type] => utility
[patent_app_number] => 16/762164
[patent_app_country] => US
[patent_app_date] => 2018-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 68
[patent_no_of_words] => 30626
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762164
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/762164 | Hematopoietic stem cells with improved properties | Nov 13, 2018 | Issued |
Array
(
[id] => 16941248
[patent_doc_number] => 11053477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-06
[patent_title] => Methods and systems for converting precursor cells into gastric tissues through directed differentiation
[patent_app_type] => utility
[patent_app_number] => 16/188597
[patent_app_country] => US
[patent_app_date] => 2018-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 17804
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16188597
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/188597 | Methods and systems for converting precursor cells into gastric tissues through directed differentiation | Nov 12, 2018 | Issued |
Array
(
[id] => 14310173
[patent_doc_number] => 20190144790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => DETERGENT COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/188624
[patent_app_country] => US
[patent_app_date] => 2018-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16188624
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/188624 | Detergent composition | Nov 12, 2018 | Issued |
Array
(
[id] => 14278005
[patent_doc_number] => 20190136287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => Microbial Ecology Shift Assay
[patent_app_type] => utility
[patent_app_number] => 16/181590
[patent_app_country] => US
[patent_app_date] => 2018-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16181590
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/181590 | Microbial Ecology Shift Assay | Nov 5, 2018 | Abandoned |
Array
(
[id] => 16420597
[patent_doc_number] => 20200345795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => MODULATION OF INTESTINAL MICROBIOTA IN PRE-DIABETES AND TYPE 2 DIABETES
[patent_app_type] => utility
[patent_app_number] => 16/760577
[patent_app_country] => US
[patent_app_date] => 2018-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760577
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/760577 | MODULATION OF INTESTINAL MICROBIOTA IN PRE-DIABETES AND TYPE 2 DIABETES | Oct 31, 2018 | Abandoned |
Array
(
[id] => 14649201
[patent_doc_number] => 20190231729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => DISORDERS IMPLICATING PUFA OXIDATION
[patent_app_type] => utility
[patent_app_number] => 16/171889
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16171889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/171889 | DISORDERS IMPLICATING PUFA OXIDATION | Oct 25, 2018 | Abandoned |
Array
(
[id] => 15038615
[patent_doc_number] => 20190330312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => MICROORGANISM FOR DELIVERING DRUG FOR TREATMENT OF GASTROINTESTINAL DISEASE, WHICH EXPRESSES AND SECRETES CYSTATIN, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING GASTROINTESTINAL DISEASE, WHICH INCLUDES THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/471912
[patent_app_country] => US
[patent_app_date] => 2018-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471912
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471912 | Microorganism for delivering drug for treatment of gastrointestinal disease, which expresses and secretes cystatin, and pharmaceutical composition for preventing or treating gastrointestinal disease, which includes the same | Oct 15, 2018 | Issued |
Array
(
[id] => 15324685
[patent_doc_number] => 20200002672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => ACTIVATION OF IMMUNE CELLS
[patent_app_type] => utility
[patent_app_number] => 16/160006
[patent_app_country] => US
[patent_app_date] => 2018-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16160006
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/160006 | Activation of immune cells | Oct 14, 2018 | Issued |
Array
(
[id] => 17135777
[patent_doc_number] => 11137327
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Isolation, detection and use of biological cells
[patent_app_type] => utility
[patent_app_number] => 16/158219
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 43848
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16158219
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/158219 | Isolation, detection and use of biological cells | Oct 10, 2018 | Issued |
Array
(
[id] => 18478442
[patent_doc_number] => 11692173
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Method for inducing differentiation of pluripotent stem cells into hepatocytes
[patent_app_type] => utility
[patent_app_number] => 16/755490
[patent_app_country] => US
[patent_app_date] => 2018-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9415
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16755490
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/755490 | Method for inducing differentiation of pluripotent stem cells into hepatocytes | Oct 8, 2018 | Issued |
Array
(
[id] => 13904203
[patent_doc_number] => 20190041306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => Isolation, Detection and Use of Biological Cells
[patent_app_type] => utility
[patent_app_number] => 16/154628
[patent_app_country] => US
[patent_app_date] => 2018-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43847
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16154628
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/154628 | Isolation, detection and use of biological cells | Oct 7, 2018 | Issued |
Array
(
[id] => 18171756
[patent_doc_number] => 11571449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Pharmaceutical composition comprising a combination of probiotic and prebiotic to treat stunting
[patent_app_type] => utility
[patent_app_number] => 16/652059
[patent_app_country] => US
[patent_app_date] => 2018-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9723
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652059
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/652059 | Pharmaceutical composition comprising a combination of probiotic and prebiotic to treat stunting | Oct 3, 2018 | Issued |
Array
(
[id] => 13843697
[patent_doc_number] => 20190025333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => B-TYPE NATRIURETIC PEPTIDE PROTEOLYTIC ASSAY FOR CARDIOVASCULAR DISEASE RISK ASSESSMENT
[patent_app_type] => utility
[patent_app_number] => 16/152336
[patent_app_country] => US
[patent_app_date] => 2018-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16152336
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/152336 | B-type natriuretic peptide proteolytic assay for cardiovascular disease risk assessment | Oct 3, 2018 | Issued |
Array
(
[id] => 14072797
[patent_doc_number] => 20190085286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => Cell Freezing Kits and Their Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/141321
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16141321
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/141321 | Cell Freezing Kits and Their Use Thereof | Sep 24, 2018 | Abandoned |
Array
(
[id] => 14099147
[patent_doc_number] => 20190091249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => GLYCAN THERAPEUTIC COMPOSITIONS AND RELATED METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/140091
[patent_app_country] => US
[patent_app_date] => 2018-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16140091
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/140091 | Glycan therapeutic compositions and related methods thereof | Sep 23, 2018 | Issued |
Array
(
[id] => 14773451
[patent_doc_number] => 20190261623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => CELL COMPOSITION AND METHODS OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/138940
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16138940
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/138940 | CELL COMPOSITION AND METHODS OF MAKING THE SAME | Sep 20, 2018 | Abandoned |
Array
(
[id] => 16892074
[patent_doc_number] => 11033601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Selective inhibition of V1b for treating fatty liver
[patent_app_type] => utility
[patent_app_number] => 16/131410
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 6003
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16131410
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/131410 | Selective inhibition of V1b for treating fatty liver | Sep 13, 2018 | Issued |